Literature DB >> 32742131

Predictors of irreversible intestinal resection in patients with acute mesenteric venous thrombosis.

Shi-Long Sun1, Xin-Yu Wang1, Cheng-Nan Chu1, Bao-Chen Liu1, Qiu-Rong Li1, Wei-Wei Ding1.   

Abstract

BACKGROUND: Acute mesenteric venous thrombosis (AMVT) can cause a poor prognosis. Prompt transcatheter thrombolysis (TT) can achieve early mesenteric revascularization. However, irreversible intestinal ischemia still occurs and the mechanism is still unclear. AIM: To evaluate the clinical outcomes of and to identify predictive factors for irreversible intestinal ischemia requiring surgical resection in AMVT patients treated by TT.
METHODS: The records of consecutive patients with AMVT treated by TT from January 2010 to October 2017 were retrospectively analyzed. We compared patients who required resection of irreversible intestinal ischemia to patients who did not require.
RESULTS: Among 58 patients, prompt TT was carried out 28.5 h after admission. A total of 42 (72.4%) patients underwent arteriovenous combined thrombolysis, and 16 (27.6%) underwent arterial thrombolysis alone. The overall 30-d mortality rate was 8.6%. Irreversible intestinal ischemia was indicated in 32 (55.2%) patients, who had a higher 30-d mortality and a longer in-hospital stay than patients without resection. The significant independent predictors of irreversible intestinal ischemia were Acute Physiology and Chronic Health Evaluation (APACHE) II score (odds ratio = 2.368, 95% confidence interval: 1.047-5.357, P = 0.038) and leukocytosis (odds ratio = 2.058, 95% confidence interval: 1.085-3.903, P = 0.027). Using the receiver operating characteristic curve, the cutoff values of the APACHE II score and leukocytosis for predicting the onset of irreversible intestinal ischemia were calculated to be 8.5 and 12 × 109/L, respectively.
CONCLUSION: Prompt TT could achieve a favorable outcome in AMVT patients. High APACHE II score and leukocytosis can significantly predict the occurrence of irreversible intestinal ischemia. Therefore, close monitoring of these factors may help with the early identification of patients with irreversible intestinal ischemia, in whom ultimately surgical resection is required, before the initiation of TT. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Acute Physiology and Chronic Health Evaluation II score; Acute mesenteric venous thrombosis; Irreversible intestinal ischemia; Leukocytosis; Surgical resection; Transcatheter thrombolysis

Mesh:

Year:  2020        PMID: 32742131      PMCID: PMC7366062          DOI: 10.3748/wjg.v26.i25.3625

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

Review 1.  Mesenteric ischemia: the whole spectrum.

Authors:  M J Sise
Journal:  Scand J Surg       Date:  2010       Impact factor: 2.360

2.  Clinical Features and Outcomes of Patients With Acute Mesenteric Ischemia and Concomitant Colon Ischemia: A Retrospective Cohort Study.

Authors:  Shuofei Yang; Yiping Zhao; Jiaquan Chen; Qihong Ni; Xiangjiang Guo; Xiaozhong Huang; Guanhua Xue; Lan Zhang
Journal:  J Surg Res       Date:  2018-08-31       Impact factor: 2.192

3.  Damage control surgery in a non-trauma setting.

Authors:  J O Jansen; M A Loudon
Journal:  Br J Surg       Date:  2007-07       Impact factor: 6.939

4.  Balloon dilation when using double-balloon enteroscopy for small-bowel strictures associated with ischemic enteritis.

Authors:  Naoyuki Nishimura; Hironori Yamamoto; Tomonori Yano; Yoshikazu Hayashi; Hiroyuki Sato; Yoshimasa Miura; Hakuei Shinhata; Keijiro Sunada; Kentaro Sugano
Journal:  Gastrointest Endosc       Date:  2011-09-15       Impact factor: 9.427

Review 5.  Clinical approach to splanchnic vein thrombosis: risk factors and treatment.

Authors:  Nicoletta Riva; Marco P Donadini; Francesco Dentali; Alessandro Squizzato; Walter Ageno
Journal:  Thromb Res       Date:  2012-10       Impact factor: 3.944

6.  Small intestinal stricture complicating superior mesenteric vein thrombosis. A study of three cases.

Authors:  C Eugène; D Valla; L Wesenfelder; A Fingerhut; A Bergue; J Merrer; C Felsenheld; A Moundji; J C Etienne
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

7.  Impact of etiologic factors and APACHE II and POSSUM scores in management and clinical outcome of acute intestinal ischemic disorders after surgical treatment.

Authors:  Hui-Ping Hsu; Yan-Shen Shan; Yu-Hsiang Hsieh; Edgar D Sy; Pin-Wen Lin
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 8.  Mesenteric venous thrombosis.

Authors:  Ashwani K Singal; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2013-02-27       Impact factor: 7.616

9.  Multidisciplinary stepwise management strategy for acute superior mesenteric venous thrombosis: an intestinal stroke center experience.

Authors:  Shuofei Yang; Xinxin Fan; Weiwei Ding; Baochen Liu; Jiaxiang Meng; Dandan Xu; Changsheng He; Wenkui Yu; Xingjiang Wu; Jieshou Li
Journal:  Thromb Res       Date:  2014-11-10       Impact factor: 3.944

10.  Transcatheter thrombolysis combined with damage control surgery for treatment of acute mesenteric venous thrombosis associated with bowel necrosis: a retrospective study.

Authors:  Kai Liu; Jiaxiang Meng; Shuofei Yang; Baochen Liu; Weiwei Ding; Xingjiang Wu; Jieshou Li
Journal:  World J Emerg Surg       Date:  2015-10-29       Impact factor: 5.469

View more
  1 in total

1.  Acute mesenteric ischemia due to percutaneous coronary intervention: A case report.

Authors:  Peng Ding; Yuan Zhou; Kun-Lan Long; Song Zhang; Pei-Yang Gao
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.